Comirnaty
COVID-19 Vaccine, mRNA · Injection, Suspension · Intramuscular
No FDA structured label text is available for Comirnaty. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
- Bnt162b2 Omicron (lp.8.1) in 2 products
- Bnt-162b2 Omicron (xfg) Mrna in 2 products
Comirnaty NDC products (4)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 0069-2501 | Bnt162b2 Omicron (lp.8.1) .0158 mg/.48mL Injection, Suspension | Pfizer Laboratories Div Pfizer Inc | BLA |
| 0069-2528 | Bnt162b2 Omicron (lp.8.1) .042 mg/.418mL Injection, Suspension | Pfizer Laboratories Div Pfizer Inc | BLA |
| 0069-2609 | Bnt-162b2 Omicron (xfg) Mrna .0158 mg/.48mL Injection, Suspension | Pfizer Laboratories Div Pfizer Inc | BLA |
| 0069-2631 | Bnt-162b2 Omicron (xfg) Mrna .042 mg/.418mL Injection, Suspension | Pfizer Laboratories Div Pfizer Inc | BLA |
Frequently asked questions
Who makes Comirnaty?
Comirnaty is listed by 1 labeler in the FDA NDC directory, including Pfizer Laboratories Div Pfizer Inc.